查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462937

同種異體幹細胞移植市場，按細胞類型、來源、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Allogeneic Stem Cell Transplantation Market, By Cell Type, By Source, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年異體幹細胞移植市場規模為38.3334億美元，2024年至2032年複合CAGR為7.8%。

異體幹細胞移植市場-市場動態

血液系統惡性腫瘤和非惡性疾病盛行率上升推動市場需求

由於血液系統惡性腫瘤和非惡性疾病盛行率上升，同種異體幹細胞移植市場預計將大幅成長，這種移植方法已顯示出前景。此外，研發投資的增加以及幹細胞療法的強大管道預計將推動市場擴張。探索各個治療領域的同種異體幹細胞移植的臨床試驗數量不斷增加，這預示著未來市場的成長。癌症、自體免疫疾病和血液疾病等慢性疾病發生率的增加是同種異體幹細胞移植市場的關鍵驅動力。過去十年來，白血病、多發性骨髓瘤和淋巴瘤等疾病的病例都穩定上升。同種異體造血幹細胞移植為許多這些高風險和抗藥性血液惡性腫瘤提供了潛在的治療方法。據世界衛生組織 (WHO) 稱，2020 年，癌症在全球造成近 1000 萬人死亡。目前正在進行大量研究和臨床試驗，以評估同種異體幹細胞療法在傳統血癌和疾病之外的新應用的安全性和有效性。多項第 2 期和第 3 期試驗正在研究同種異體幹細胞療法治療骨髓纖維化、骨關節炎、中風、創傷性腦損傷和心肌炎等疾病。旨在擴大治療領域的穩健管道活動將為市場成長開闢新途徑。例如，全球製藥公司諾華公司已啟動一項利用同種異體幹細胞移植治療骨髓纖維化的2期臨床試驗，預計完成日期為2024年10月。

同種異體幹細胞移植市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 7.8% 左右的CAGR成長

根據來源細分，預計骨髓將在 2023 年顯示最大的市場佔有率

根據最終用戶細分，醫院是 2023 年的領先類型

按地區分類，北美是 2023 年的主要收入來源

同種異體幹細胞移植市場-細分分析：

全球同種異體幹細胞移植市場根據細胞類型、來源、應用、最終用戶和地區進行細分。

市場依來源分為兩類：骨髓、週邊血、臍帶血、脂肪組織、牙髓等。骨髓同種異體幹細胞移植市場預計在 2023 年佔據重要的全球市場佔有率。 。對於符合條件的個人來說，這種治療方式至關重要，因為它有可能顯著延長預期壽命，並且通常不會復發。

根據最終用戶，市場分為三類：醫院、研究所、專科診所和其他。到 2023 年，醫院最終用戶部分將主要貢獻於同種異體幹細胞移植服務，這主要是由於現代醫院內擁有先進的醫療基礎設施。值得注意的是，當代醫院配備了尖端的醫療技術，包括專門從事骨髓移植的專業單位。這些資源使醫院能夠為造血幹細胞移植 (HSCT) 接受者提供全面的移植前和移植後護理，特別是在美國、德國、英國、中國和印度等地區。

同種異體幹細胞移植市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

同種異體幹細胞移植市場-競爭格局：

公司和醫療機構正在實施策略措施，以改善患者的治療效果、促進創新並增加獲得移植服務的機會。該策略的一個重要方面涉及透過專門的研究和開發努力不斷進步移植技術和方案。這包括對移植物抗宿主疾病（GVHD）創新預防方法的投資、預處理方案的完善以及探索替代幹細胞來源以擴大資格標準並提高移植成功率。與學術機構和研究組織的合作在驗證和最佳化這些進步、確保其臨床適用性和有效性方面發揮著至關重要的作用。

最近的發展：

2023年9月，法國生技公司MaaT Pharma宣布，歐洲藥品管理局（EMA）已授予MaaT033孤兒藥資格。 MaaT033 由 MaaT Pharma 開發，是一種輔助和維持療法，旨在提高同種異體造血幹細胞移植（allo-HSCT）的整體存活率。

目錄

第1章：同種異體幹細胞移植市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按細胞類型分類的同種異體幹細胞移植市場片段
    • 同種異體幹細胞移植市場片段（依來源）
    • 同種異體幹細胞移植市場片段（依應用）
    • 最終用戶的同種異體幹細胞移植市場片段
    • 按國家/地區分類的同種異體幹細胞移植市場片段
    • 按地區分類的同種異體幹細胞移植市場片段
  • 競爭洞察

第 3 章：同種異體幹細胞移植主要市場趨勢

  • 同種異體幹細胞移植市場促進因素
    • 市場促進因素的影響分析
  • 同種異體幹細胞移植市場限制
    • 市場限制影響分析
  • 同種異體幹細胞移植市場機會
  • 異體幹細胞移植市場未來趨勢

第4章：同種異體幹細胞移植產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：同種異體幹細胞移植市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：同種異體幹細胞移植市場格局

  • 2023 年同種異體幹細胞移植市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：同種異體幹細胞移植市場 - 依細胞類型

  • 概述
    • 按電池類型分類的細分市場佔有率分析
    • 同種異體間質幹細胞
    • 同種異體造血幹細胞
    • 其他

第 8 章：同種異體幹細胞移植市場 - 按來源

  • 概述
    • 按來源分類的細分市場佔有率分析
    • 骨髓
    • 週邊血
    • 臍帶血
    • 脂肪組織
    • 牙髓
    • 其他

第 9 章：同種異體幹細胞移植市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 癌症
    • 自體免疫疾病
    • 血液疾病
    • 心臟疾病
    • 神經系統疾病
    • 糖尿病
    • 其他

第 10 章：同種異體幹細胞移植市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 研究機構
    • 專科診所
    • 其他

第 11 章：同種異體幹細胞移植市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美同種異體幹細胞移植主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按電池類型）
    • 北美市場規模與預測（按來源）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲同種異體幹細胞移植主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按電池類型）
    • 歐洲市場規模與預測（按來源）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區同種異體幹細胞移植主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按電池類型）
    • 亞太地區市場規模與預測（按來源）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲同種異體幹細胞移植主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按電池類型）
    • 拉丁美洲市場規模與預測（按來源）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲同種異體幹細胞移植主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按電池類型）
    • 中東和非洲市場規模及預測（按來源）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第12章：主要供應商分析-同種異體幹細胞移植產業

  • 競爭儀表板
  • 公司簡介
    • Celgene Corporation
    • Mesoblast Ltd.
    • Pluristem Therapeutics Inc.
    • MEDIPOST Co., Ltd.
    • Osiris Therapeutics, Inc.
    • Cynata Therapeutics Limited
    • Takeda Pharmaceutical Company Limited
    • Astellas Pharma Inc.
    • Cellular Biomedicine Group, Inc.
    • Biosolution Co., Ltd.
    • StemCell Technologies Inc.
    • Caladrius Biosciences, Inc.
    • ViaCord
    • Vericel Corporation
    • Regen Biopharma Inc.
    • Gamida Cell Ltd.
    • Histogenics Corporation
    • BrainStorm Cell Therapeutics Inc.
    • Lineage Cell Therapeutics, Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2395

REPORT HIGHLIGHT

Allogeneic Stem Cell Transplantation Market size was valued at USD 3,833.34 Million in 2023, expanding at a CAGR of 7.8% from 2024 to 2032.

Allogeneic stem cell transplantation involves the transfer of healthy stem cells from a genetically compatible donor to the patient, replacing damaged cells. This established therapeutic technique is used to address various hematological cancers, blood disorders, and immunological conditions. Stem cells for allogeneic transplants can be sourced from peripheral blood, bone marrow, umbilical cord blood, or adipose tissue. The field has witnessed significant progress in harvesting methods, expansion protocols, cryopreservation, and cell processing.

Allogeneic Stem Cell Transplantation Market- Market Dynamics

Rising prevalence of hematologic malignancies and non-malignant disorders to propel market demand

The Allogeneic Stem Cell Transplantation Market is expected to witness substantial growth driven by the rising prevalence of hematologic malignancies and non-malignant disorders, where this transplantation method has shown promise. Additionally, increased investments in research and development, along with a robust pipeline of stem cell therapies, are anticipated to propel market expansion. The rising number of clinical trials exploring allogeneic stem cell transplantation across various therapeutic areas bodes well for future market growth. The increasing incidence of chronic diseases like cancer, autoimmune disorders, and blood ailments is a key driver for the allogeneic stem cell transplantation market. Cases of diseases such as leukemia, multiple myeloma, and lymphoma have steadily risen over the past decade. Allogeneic hematopoietic stem cell transplantation offers a potentially curative approach for many of these high-risk and drug-resistant hematological malignancies. According to the World Health Organization (WHO), cancer caused nearly 10 million deaths worldwide in 2020. The growing pool of patients and demand for advanced therapies to address these conditions will fuel market growth. Numerous research studies and clinical trials are underway to assess the safety and efficacy of allogeneic stem cell therapies for new applications beyond traditional blood cancers and disorders. Several phase 2 and 3 trials are investigating allogeneic stem cell therapies for conditions such as bone marrow fibrosis, osteoarthritis, stroke, traumatic brain injury, and myocarditis, among others. Robust pipeline activities aimed at expanding the treatment landscape will open up new avenues for market growth. For example, Novartis, a global pharmaceutical company, has initiated a phase 2 clinical trial using allogeneic stem cell transplantation to treat bone marrow fibrosis, with an expected completion date of October 2024.

Allogeneic Stem Cell Transplantation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.8% over the forecast period (2024-2032)

Based on Source segmentation, Bone Marrow was predicted to show maximum market share in the year 2023

Based on End User segmentation, Hospitals was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Allogeneic Stem Cell Transplantation Market- Segmentation Analysis:

The Global Allogeneic Stem Cell Transplantation Market is segmented on the basis of Cell Type, Source, Application, End User, and Region.

The market is divided into two categories based on Source: Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Dental Pulp, and Others. The bone marrow allogeneic stem cell transplantation market is poised to command a significant global market share in 2023. Bone marrow stem cell transplantation emerges as a promising therapeutic avenue for select hematological disorders, particularly in cases where conventional treatments have proven ineffective or disease recurrence has transpired. For eligible individuals, this treatment modality holds paramount importance as it offers the potential to extend life expectancy significantly, often free from relapse.

The market is divided into three categories based on End User: Hospitals, Research Institutes, Specialty Clinics, and Others. In 2023, the hospital end user segment predominantly contributes to allogeneic stem cell transplantation services, primarily owing to the sophisticated medical infrastructure available within modern hospitals. Notably, contemporary hospitals are equipped with cutting-edge medical technologies, including specialized units dedicated to bone marrow transplantation. These resources empower hospitals to deliver comprehensive pre- and post-transplant care to hematopoietic stem cell transplant (HSCT) recipients, particularly in regions such as the United States, Germany, the United Kingdom, China, and India.

Allogeneic Stem Cell Transplantation Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Allogeneic Stem Cell Transplantation Market- Competitive Landscape:

Companies and healthcare institutions are implementing strategic measures to enhance patient outcomes, foster innovation, and enhance access to transplantation services. A crucial aspect of this strategy involves continual advancements in transplant technologies and protocols through dedicated research and development endeavors. This encompasses investments in innovative prophylaxis methods for graft-versus-host disease (GVHD), refinement of conditioning regimens, and exploration of alternative stem cell sources to broaden eligibility criteria and enhance transplant success rates. Collaborations with academic institutions and research organizations play a vital role in validating and optimizing these advancements, ensuring their clinical applicability and effectiveness.

Recent Developments:

In September 2023, MaaT Pharma, a biotechnology company based in France, announced that the European Medicines Agency (EMA) has granted orphan drug designation to MaaT033. Developed by MaaT Pharma, MaaT033 is an adjunctive and maintenance therapy aimed at improving overall survival in Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Celgene Corporation

Mesoblast Ltd.

Pluristem Therapeutics Inc.

MEDIPOST Co., Ltd.

Osiris Therapeutics, Inc.

Cynata Therapeutics Limited

Takeda Pharmaceutical Company Limited

Astellas Pharma Inc.

Cellular Biomedicine Group, Inc.

Biosolution Co., Ltd.

StemCell Technologies Inc.

Caladrius Biosciences, Inc.

ViaCord

Vericel Corporation

Regen Biopharma Inc.

Gamida Cell Ltd.

Histogenics Corporation

BrainStorm Cell Therapeutics Inc.

Lineage Cell Therapeutics, Inc.

Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY CELL TYPE - MARKET ANALYSIS, 2019 - 2032

  • Allogeneic MSCs
  • Allogeneic HSCs
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Bone Marrow
  • Peripheral Blood
  • Umbilical Cord Blood
  • Adipose Tissue
  • Dental Pulp
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Autoimmune Diseases
  • Blood Disorders
  • Cardiac Disorders
  • Neurological Disorders
  • Diabetes
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Research Institutes
  • Specialty Clinics
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Allogeneic Stem Cell Transplantation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Allogeneic Stem Cell Transplantation Market Snippet by Cell Type
    • 2.1.2.Allogeneic Stem Cell Transplantation Market Snippet by Source
    • 2.1.3.Allogeneic Stem Cell Transplantation Market Snippet by Application
    • 2.1.4.Allogeneic Stem Cell Transplantation Market Snippet by End User
    • 2.1.5.Allogeneic Stem Cell Transplantation Market Snippet by Country
    • 2.1.6.Allogeneic Stem Cell Transplantation Market Snippet by Region
  • 2.2.Competitive Insights

3.Allogeneic Stem Cell Transplantation Key Market Trends

  • 3.1.Allogeneic Stem Cell Transplantation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Allogeneic Stem Cell Transplantation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Allogeneic Stem Cell Transplantation Market Opportunities
  • 3.4.Allogeneic Stem Cell Transplantation Market Future Trends

4.Allogeneic Stem Cell Transplantation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Allogeneic Stem Cell Transplantation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Allogeneic Stem Cell Transplantation Market Landscape

  • 6.1.Allogeneic Stem Cell Transplantation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Allogeneic Stem Cell Transplantation Market - By Cell Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
    • 7.1.2.Allogeneic MSCs
    • 7.1.3.Allogeneic HSCs
    • 7.1.4.Others

8.Allogeneic Stem Cell Transplantation Market - By Source

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Source, 2023 & 2032 (%)
    • 8.1.2.Bone Marrow
    • 8.1.3.Peripheral Blood
    • 8.1.4.Umbilical Cord Blood
    • 8.1.5.Adipose Tissue
    • 8.1.6.Dental Pulp
    • 8.1.7.Others

9.Allogeneic Stem Cell Transplantation Market - By Application

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2.Cancer
    • 9.1.3.Autoimmune Diseases
    • 9.1.4.Blood Disorders
    • 9.1.5.Cardiac Disorders
    • 9.1.6.Neurological Disorders
    • 9.1.7.Diabetes
    • 9.1.8.Others

10.Allogeneic Stem Cell Transplantation Market - By End User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2.Hospitals
    • 10.1.3.Research Institutes
    • 10.1.4.Specialty Clinics
    • 10.1.5.Others

11.Allogeneic Stem Cell Transplantation Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Allogeneic Stem Cell Transplantation Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Allogeneic Stem Cell Transplantation Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Celgene Corporation
    • 12.2.2.Mesoblast Ltd.
    • 12.2.3.Pluristem Therapeutics Inc.
    • 12.2.4.MEDIPOST Co., Ltd.
    • 12.2.5.Osiris Therapeutics, Inc.
    • 12.2.6.Cynata Therapeutics Limited
    • 12.2.7.Takeda Pharmaceutical Company Limited
    • 12.2.8.Astellas Pharma Inc.
    • 12.2.9.Cellular Biomedicine Group, Inc.
    • 12.2.10.Biosolution Co., Ltd.
    • 12.2.11.StemCell Technologies Inc.
    • 12.2.12.Caladrius Biosciences, Inc.
    • 12.2.13.ViaCord
    • 12.2.14.Vericel Corporation
    • 12.2.15.Regen Biopharma Inc.
    • 12.2.16.Gamida Cell Ltd.
    • 12.2.17.Histogenics Corporation
    • 12.2.18.BrainStorm Cell Therapeutics Inc.
    • 12.2.19.Lineage Cell Therapeutics, Inc.
    • 12.2.20.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Allogeneic Stem Cell Transplantation Market: Cell Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Cell Type 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: Source Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Source
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Source 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Application 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by End User 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Allogeneic Stem Cell Transplantation Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Cell Type segment market share analysis, 2023 & 2032
  • FIGURE Cell Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Source segment market share analysis, 2023 & 2032
  • FIGURE Source segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Allogeneic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Europe Allogeneic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Asia Pacific Allogeneic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Latin America Allogeneic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Middle East and Africa Allogeneic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Allogeneic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE Germany Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Allogeneic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE India Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Allogeneic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE Brazil Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Allogeneic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE Saudi Arabia Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)